Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
BackgroundGlioblastoma (GBM) is the deadliest form of brain cancer, impacting both adults and children, marked by exceptionally high morbidity and mortality rates, even with current standard treatments such as surgery, radiation therapy, and chemotherapy. Therefore, there is a pressing need for new...
Saved in:
Main Authors: | Julia Uffenorde, Mehran Hariri, Eleftherios Papalanis, Annika Staffas, Josefine Berg, Bo Stenerlöw, Hanna Berglund, Christer Malmberg, Diana Spiegelberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1451156/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Self-replicating recombinant virus-like particles of lentivirus proliferating in glioblastoma cells and normal human macrophages
by: Herman D. Moshkoff, et al.
Published: (2024-11-01) -
Diagnostic impact of DNA methylation classification in adult and pediatric CNS tumors
by: Laetitia Lebrun, et al.
Published: (2025-01-01) -
Unusual presentation of secondary CNS lymphoma with punctate intralesional and intraventricular hemorrhage
by: Daniel De-Liang Loh, et al.
Published: (2025-04-01) -
Case Series of Anthrax in Iran
by: Kiana Shirani, et al.
Published: (2025-01-01) -
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01)